Akorn, Inc. And Natco Pharma Limited Add Two Injectable Drug Products To API Supply And Margin Sharing Agreement

November 2, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Akorn, Inc. (AMEX: AKN) today announced that it has added two injectable drug products to its API Supply and Margin Sharing Agreement with Natco Pharma Limited (NSE: NATCOPHARM)(BSE: 524816).

Twitter
LinkedIn
Facebook
Email
Print

Alliances